[go: up one dir, main page]

CO4410193A1 - Heteroaril-oxazolidinonas de 5 eslabones - Google Patents

Heteroaril-oxazolidinonas de 5 eslabones

Info

Publication number
CO4410193A1
CO4410193A1 CO95031767A CO95031767A CO4410193A1 CO 4410193 A1 CO4410193 A1 CO 4410193A1 CO 95031767 A CO95031767 A CO 95031767A CO 95031767 A CO95031767 A CO 95031767A CO 4410193 A1 CO4410193 A1 CO 4410193A1
Authority
CO
Colombia
Prior art keywords
carbon
atoms
branched
linear
different
Prior art date
Application number
CO95031767A
Other languages
English (en)
Inventor
Bernd Riedl
Dieter Habich
Andreas Stolle
Hanno Wild
Rainer Endermann
Hein-Peter Kroll
Harald Labischinski
Klaus Schaller
Hans-Otto Werling
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CO4410193A1 publication Critical patent/CO4410193A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

REIVINDICACION HETEROARIL-OXAZOLIDINONAS, DE FORMULA GENERAL(I) FIGURA NO. 1 EN LA CUAL R1 REPRESENTA AZIDO, HIDROXILO O UN GRUPO DE FOR- MULA -OR2, -O-SO(SUBIND)2R3 o -NR4R5 EN DONDE R2 SIGNIFICA ACILO, LINEAL O RAMIFICADO, CON HAS- TA 8 ATOMOS DE CARBONO O UN GRUPO PROTECTOR HIDRO- XILO, R3 SIGNIFICA ALQUILO, LINEAL O RAMIFICADO, CON HASTA 4 ATOMOS DE CARBONO O FENILO QUE, DADO EL CASO, ESTA SUSTITUIDO POR ALQUILO, LINEAL O RAMI- FICADO, CON HASTA 4 ATOMOS DE CARBONO, R4 Y R5 SON IGUALES O DISTINTOS Y SIGNIFICAN DICLOALQUILO CON 3 A 6 ATOMOS DE CARBO- NO, HIDROGENO, FENILO O ALQUILO, LINEAL O RAMIFI- CADO, CON HASTA 8 ATOMOS DE CARBONO O UN GRUPO PROTECTOR DE AMINO, O R4 o R5 SIGNIFICAN UN GRUPO DE FORMULA -CO-R6, EN DONDE R6 SIGNIFICA CICLOALQUILO CON 3 A 6 ATOMOS DE CAR- BONO, ALQUILO, LINEAL O RAMIFICADO, CON HASTA 8 A- TOMOS DE CARBONO, FENILO O HIDROGENO, A REPRESENTA UN HETEROCICLO AROMATICO DE 5 ESLA- BONES, UNIDO DIRECTAMENTE SOBRE EL ATOMO DE CARBO- NO, CON HASTA 3 HETEROATOMOS DEL GRUPO S, N y/u O QUE, ADICIONALMENTE PUEDE POSEER UN ANILLO DE BEN- CENO O NAFTALENO CONDENSADO, DONDE LOS CICLOS, DA- DO EL CASO, ESTAN HASTA TRISUSTITUIDOS RESPECTIVA- MENTE, POR SUSTITUYENTES IGUALES O DISTINTOS, CAR- BOXI, HALOGENO, CIANO, MERCAPTO, FORMILO, TRIFLU- ORMETILO, NITRO, ALCOXI, ALCOXICARBONILO, ALQUIL- TIO O ACILO, O RAMIFICADO, CON HASTA 6 ATOMOS DE CARBONO RESPECTIVAMENTE O POR ALQUILO LINEAL O RA- MIFICADO CON HASTA 6 ATOMOS DE CARBONO QUE, POR SU PARTE, PUEDE ESTAR SUSTITUIDO POR HIDROXILO, ALCO- XI O ACILO, LINEAL O RAMIFICADO, CON HASTA 5 ATO- MOS DE CARBONO O POR UN GRUPO DE FORMULA -NR7R4, EN DONDE R7 y R8 SON IGUALES O DISTINTOS Y SIGNIFICAN HIDROGENO, ALQUILO, LINEAL O RAMIFICA- DO, CON HASTA 4 ATOMOS DE CARBONO O FENILO, O, JUNTO CON EL ATOMO DE NITROGENO FORMAN UN HETERO- CICLO SATURADO DE 5 A 6 ESLABONES, DADO EL CASO CON OTRO HETEROATOMO DEL GRUPO N, S y/u O QUE, POR SU PARTE, PUEDE ESTAR SUSTITUIDO TAMBIEN, DADO EL CASO, EN OTRO ATOMO DE NITROGENO POR ALQUILO O A- CILO, LINEAL O RAMIFICADO, CON HASTA e ATOMOS DE CARBONO, Y/O LOS CICLOS ESTAN SUSTITUIDOS, DADO EL CASO, POR UN GRUPO DE FORMULA -NR7´R8´, EN DONDE R7´ Y R8´ SON IGUALES O DISTINTOS Y TIENEN EL SIG- NIFICADO INDICADO MAS ARRIBA PARA R7 Y R8 Y SON I- GUALES O DISTINTOS A ESTOS, Y/O LOS CICLOS ESTAN SUSTITUIDOS, DADO EL CASO, POR (C2-C8)-ALQUENILFENILO, FENILO O POR UN HETEROCI- CLO SATURADO O INSATURADO DE 5 o 6 ESLABONES, CON HASTA e HETEROATOMOS DEL GRUPO S, N y/u O, QUE POR SU PARTE ESTAN SUSTITUIDOS, DADO EL CASO, POR UN GRUPO DE FORMULA -CO-NR9R10, NR11R12, NR13-S(O2)- R14, R15R16N-SO2 o R17-S(O)a- EN DONDE a SIGNIFICA UN NUMERO 0, 1 o 2, R9, R10, R13, R15 y R16 SON IGUALES O DISTINTOS Y SIGNIFICAN HIDROGENO, ALQUILO, LINEAL O RAMIFICA- DO, CON HASTA 6 ATOMOS DE CARBONO O FENILO R11 y R12 SON IGUALES O DISTINTOS Y TIENEN EL SIG- NIFICADO INDICADO MAS ARRIBA PARA R7 Y R8 Y SON I- GUALES O DISTINTOS A ESTOS, R14 Y R17 SON IGUALES O DISTINTOS Y TIENEN EL SIG- NIFICADO INDICADO MAS ARRIBA PARA R3 Y SON IGUALES O DISTINTOS A ESTE, Y/O POR SU PARTE, DADO EL CA- SO, ESTAN HASTA BISUSTITUIDOS, POR SUSTITUYENTES IGUALES O DISTINTOS CARBOXI, HALOGENO, CIANO, MER- CAPTO, FORMILO, TRIFLUORMETILO, NITRO, FENILO, AL- COXI, ALCOXICARBONILO, ALQUITIO O ACILO, LINEAL O RAMIFICADO, CON HASTA 6 ATOMOS DE CARBONO RESPEC- TIVAMENTE O POR ALQUILO LINEAL O RAMIFICADO CON HASTA 6 ATOMOS DE CARBONO QUE, POR SU PARTE, PUEDE ESTAR SUSTITUIDO POR HIDROXILO, POR ALCOXI O ACI- LO, LINEAL O RAMIFICADO, CON HASTA 5 ATOMOS DE CARBONO O POR UN GRUPO DE FORMULA -NR18R19, EN DONDE R18 Y R19 TIENEN EL SIGNIFICADO INDICADO MAS ARRI- BA PARA R7 Y R8 Y SON IGUALES O DISTINTOS A ESTOS, Y/O LOS CICLOS ESTAN SUSTITUIDOS, DADO EL CASO, POR UN RESTO DE FORMULA FIGURA 2 EN DONDE n SIGNIFICA UN NUMERO 0, 1 o 2 Y SUS SALES Y S-OXIDOS.
CO95031767A 1994-07-20 1995-07-18 Heteroaril-oxazolidinonas de 5 eslabones CO4410193A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4425613A DE4425613A1 (de) 1994-07-20 1994-07-20 5-gliedrige Heteroaryl-oxazolidinone

Publications (1)

Publication Number Publication Date
CO4410193A1 true CO4410193A1 (es) 1997-01-09

Family

ID=6523633

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95031767A CO4410193A1 (es) 1994-07-20 1995-07-18 Heteroaril-oxazolidinonas de 5 eslabones

Country Status (28)

Country Link
US (1) US5698574A (es)
EP (1) EP0693491A1 (es)
JP (1) JPH0853443A (es)
KR (1) KR960004343A (es)
CN (1) CN1121919A (es)
AU (1) AU695661B2 (es)
BG (1) BG99791A (es)
CA (1) CA2154026A1 (es)
CO (1) CO4410193A1 (es)
CZ (1) CZ187395A3 (es)
DE (1) DE4425613A1 (es)
EE (1) EE9500044A (es)
FI (1) FI953476L (es)
HR (1) HRP950391A2 (es)
HU (1) HUT74003A (es)
IL (1) IL114622A (es)
MA (1) MA23621A1 (es)
NO (1) NO304488B1 (es)
NZ (1) NZ272596A (es)
PE (1) PE35896A1 (es)
PL (1) PL309685A1 (es)
RO (1) RO115161B1 (es)
RU (1) RU95113086A (es)
SK (1) SK91695A3 (es)
SV (1) SV1995000042A (es)
TN (1) TNSN95083A1 (es)
YU (1) YU49195A (es)
ZA (1) ZA956015B (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425609A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
NZ302844A (en) * 1995-02-03 1999-06-29 Upjohn Co Antimicrobial hetero-aromatic ring substituted phenyloxazolidinones
US6124334A (en) * 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
MX9801578A (es) * 1995-09-01 1998-08-30 Upjohn Co Feniloxazolidinonas que tienen un enlace c-c para anillos heterociclicos de 4-8 miembros.
DE19601264A1 (de) * 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19604223A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
HRP970049A2 (en) 1996-02-06 1998-04-30 Bayer Ag New heteroaryl oxazolidinones
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
ES2186916T3 (es) * 1996-08-21 2003-05-16 Upjohn Co Derivados de isoxazolina como agentes antimicrobianos.
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
JP2002501059A (ja) 1998-01-23 2002-01-15 ファルマシア・アンド・アップジョン・カンパニー オキサゾリジノンの組合せライブラリー、組成物および調製方法
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US6262044B1 (en) * 1998-03-12 2001-07-17 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPASES)
BR9911779A (pt) * 1998-05-12 2001-02-06 American Home Prod Benzotiofenos, benzofuranos e indóis úteis no tratamento de resistência à insulina e hiperglicemia
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6699896B1 (en) 1998-05-12 2004-03-02 Wyeth Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
US6221902B1 (en) 1998-05-12 2001-04-24 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
US6451827B2 (en) 1998-05-12 2002-09-17 Wyeth 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
US6110962A (en) * 1998-05-12 2000-08-29 American Home Products Corporation 11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho[2,3-D]thiophenes useful in the treatment of insulin resistance and hyperglycemia
US6121271A (en) * 1998-05-12 2000-09-19 American Home Products Corporation Naphtho[2,3-B]heteroar-4-yl derivatives
US6251936B1 (en) 1998-05-12 2001-06-26 American Home Products Corporation Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia
US6110963A (en) * 1998-05-12 2000-08-29 American Home Products Corporation Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
JP2002516305A (ja) 1998-05-12 2002-06-04 アメリカン・ホーム・プロダクツ・コーポレイション インスリン抵抗性および高血糖症の治療に有用な2,3,5−置換ビフェニル
PL345162A1 (en) * 1998-06-05 2001-12-03 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
MY122454A (en) 1998-06-05 2006-04-29 Upjohn Co Use of oxazolidinones for the preparation of a medicament for transdermal delivery
AU740781B2 (en) 1998-07-14 2001-11-15 Pharmacia & Upjohn Company Oxazolidinones to treat eye infections
US6420349B1 (en) 1998-08-24 2002-07-16 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
AR020660A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
AU4224699A (en) 1999-01-27 2000-08-18 Pharmacia & Upjohn Company Assays for modulators of elongation factor p activity
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6465456B2 (en) 2000-06-29 2002-10-15 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
US6544991B2 (en) 2000-06-30 2003-04-08 Pharmacia & Upjohn Company Compositions and methods for treating bacterial infections
PE20020300A1 (es) * 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
WO2002018354A1 (en) * 2000-08-31 2002-03-07 Abbott Laboratories Oxazolidinones and their use as antibacterial agents
PE20020578A1 (es) 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
ES2256331T3 (es) 2000-12-21 2006-07-16 PHARMACIA & UPJOHN COMPANY LLC Derivados de quinolina antimicrobianos y uso de los mismos para tratar infecciones bacterianas.
GB0118407D0 (en) * 2001-07-27 2001-09-19 Cipla Ltd Oxazolidinone derivatives as antibacterial agents
JP2003192773A (ja) * 2001-12-26 2003-07-09 Mitsui Chemicals Inc 生体吸収性ポリヒドロキシカルボン酸及びその製造法
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
AU2003218059A1 (en) * 2002-02-22 2003-09-09 Pharmacia Corporation Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
CA2476545A1 (en) * 2002-03-29 2003-10-16 Pharmacia & Upjohn Company Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
ATE321760T1 (de) * 2002-08-12 2006-04-15 Pharmacia & Upjohn Co Llc N-aryl-2-oxazolidinone und deren derivate
WO2004045616A1 (en) * 2002-11-21 2004-06-03 Pharmacia & Upjohn Company Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
US20060116400A1 (en) * 2002-11-28 2006-06-01 Astrazeneca Ab Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
GB0229526D0 (en) * 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
MXPA05007937A (es) * 2003-02-07 2005-09-30 Warner Lambert Co Agentes antibacterianos.
WO2004069832A2 (en) * 2003-02-07 2004-08-19 Warner-Lambert Company Llc Antibacterial agents
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
CA2536480A1 (en) * 2003-08-25 2005-03-03 Warner-Lambert Company Llc Novel antimicrobial aryloxazolidinone compounds
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
WO2008021338A2 (en) * 2006-08-15 2008-02-21 Wyeth Tricyclic oxazolidone derivatives useful as pr modulators
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
WO2008021337A1 (en) * 2006-08-15 2008-02-21 Wyeth Oxazinan-2-one derivatives useful as pr modulators
CL2008000662A1 (es) * 2007-03-09 2008-04-25 Wyeth Corp Forma cristalina de 4-(2-(4,4-dimetil-2-oxooxazolidin-3-il) tiazo-4-il) benzonitrilo; metodo para la preparacion de dicho compuesto; composicion farmaceutica que comprende a dicho compuesto; kit farmaceutico que comprende a dicho compuesto; y su uso
WO2013182070A1 (zh) * 2012-06-08 2013-12-12 四川贝力克生物技术有限责任公司 一种用于预防或治疗分支杆菌疾病的药物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL103945C (es) * 1958-09-30
DE2304589A1 (de) * 1973-01-31 1974-08-01 Bayer Ag 3-alkyloxazolinone-(2)
JPS5735589A (en) * 1980-08-11 1982-02-26 Nippon Soda Co Ltd 5-thienyloxazoline derivative, its preparation and selective herbicide
JPS59216885A (ja) * 1983-05-20 1984-12-06 Kissei Pharmaceut Co Ltd チオフエン誘導体及びその製造方法
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
JPS6183170A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規な1,3−オキサゾリジン−2−オン誘導体およびその製造法
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US5036092A (en) * 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
EP0359418B1 (en) * 1988-09-15 1994-10-12 The Upjohn Company 5'-Indolinyl-5beta-amidomethyloxazolidin-2-ones, 3-(fused-ring substituted)phenyl-5beta-amidomethyloxazolidin-2-ones and 3-(nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones
DE3902439A1 (de) * 1989-01-27 1990-08-02 Basf Ag Pflanzenschuetzende mittel auf basis von 1-aryl- bzw. 1-hetarylimidazolcarbonsaeureestern
KR100257418B1 (ko) * 1991-11-01 2000-05-15 로렌스 티. 마이젠헬더 치환된 아릴-및 헤테로아릴-페닐옥사졸리디논

Also Published As

Publication number Publication date
NO304488B1 (no) 1998-12-28
PE35896A1 (es) 1996-10-14
CZ187395A3 (en) 1996-02-14
IL114622A (en) 1999-07-14
CN1121919A (zh) 1996-05-08
JPH0853443A (ja) 1996-02-27
AU695661B2 (en) 1998-08-20
US5698574A (en) 1997-12-16
MA23621A1 (fr) 1996-04-01
KR960004343A (ko) 1996-02-23
NO952866L (no) 1996-01-22
EP0693491A1 (de) 1996-01-24
HRP950391A2 (en) 1997-06-30
RO115161B1 (ro) 1999-11-30
YU49195A (sh) 1998-12-23
FI953476A0 (fi) 1995-07-18
NO952866D0 (no) 1995-07-19
HU9502167D0 (en) 1995-09-28
IL114622A0 (en) 1995-11-27
ZA956015B (en) 1996-02-22
TNSN95083A1 (fr) 1996-02-06
CA2154026A1 (en) 1996-01-21
BG99791A (en) 1996-04-30
PL309685A1 (en) 1996-01-22
FI953476L (fi) 1996-01-21
SV1995000042A (es) 1996-03-28
HUT74003A (en) 1996-10-28
DE4425613A1 (de) 1996-01-25
EE9500044A (et) 1996-02-15
AU2498895A (en) 1996-02-01
RU95113086A (ru) 1997-06-27
SK91695A3 (en) 1996-02-07
NZ272596A (en) 1997-03-24

Similar Documents

Publication Publication Date Title
CO4410193A1 (es) Heteroaril-oxazolidinonas de 5 eslabones
CO4410392A1 (es) Benzoxazolil- y benzotiazoliloxazolidinonas
CO4370145A1 (es) Derivados de n-(3-benzofuranil) urea
MX9305489A (es) 3-(dihidrobenzofuran-5-il)benzofuran-2-onas, estabilizadores.
ES2059335T3 (es) Derivados de pirido(3,2,1-ij)-1,3,4-benzoxadiazina, procedimiento para su obtencion, preparados farmaceuticos correspondientes y productos intermedios utilizables en el procedimiento.
IT1121675B (it) Agenti di protezione contro l'esposizione alla luce,a base di derivati del dibenzoilmetano per impiego cosmetico
CO4900062A1 (es) Piridinas condensadas con heterociclos
CO5540391A2 (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibi dores de la fosfodiesterasa
IT1081144B (it) Dente amovibile per utensili da scavo come benne o simili con bloccaggio a chiavetta elastica
CO4520188A1 (es) 2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas
ES2098117T3 (es) Anilinas como agente de marcaje para aceites minerales.
CO5140110A1 (es) Nuevos antibioticos macrolidos
CO4600675A1 (es) Derivados de oxalilamino-benzofurano y benzotienilo
ES2166374T3 (es) Composiciones de derivados de polifenoles y su preparacion.
ES2104794T3 (es) 3-isoxazolilfenil-compuestos, su obtencion y su empleo.
BE841854A (fr) Compositions d'elastomeres de silicone a faible module, durcissables a la temperature ambiante
CO4990972A1 (es) Derivados de eritromicina en puente 6,11
ES2140497T3 (es) Derivados del acido galacturonico, sus procedimientos de preparacion y sus aplicaciones.
ES2098109T3 (es) Derivados de 1,2,3,4-tetrahidronaftaleno, de cromano y de tiocromano como agentes antitromboticos.
ES2137343T3 (es) Polieteres con cadenas laterales de amina impedida como estabilizadores.
ES2064057T3 (es) Unos derivados de 2-(aminoalquil)-5-(arilalquil)-1,3-dioxanos, su preparacion y su aplicacion en terapeutica.
ATE290029T1 (de) Polysiloxan und textilhilfsmittel enthaltend ein polysiloxan
CO4761067A1 (es) Nuevas heteroalioxazolidinonas
ES2185316T3 (es) Butirolactonas alfa, beta-condensadas sustituidas.
ES8706690A1 (es) Un procedimiento para la preparacion de nuevos derivados de penem.